Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Autoimmune Disease Diagnostics Market Insights
3.1. Autoimmune Disease Diagnostics– Industry snapshot
3.2. Autoimmune Disease Diagnostics- Ecosystem analysis
3.3. Autoimmune Disease Diagnostics Market dynamics
3.3.1. Autoimmune Disease Diagnostics– Market Forces
3.3.1.1. Autoimmune Disease Diagnostics Market driver analysis
3.3.1.2. Autoimmune Disease Diagnostics Market restraint/challenges analysis
3.3.1.3. Autoimmune Disease Diagnostics Market opportunity analysis
3.4. Industry analysis - Porter's five force
3.4.1. Bargaining power of supplier
3.4.2. Bargaining power of buyer
3.4.3. Threat of substitute
3.4.4. Threat of new entrant
3.4.5. Degree of competition
3.5. Autoimmune Disease Diagnostics Market PEST analysis, 2017
3.5.1. Autoimmune Disease Diagnostics Industry trends
3.5.2. Competitive Ranking Analysis
4. Autoimmune Disease Diagnostics Market Size and Forecast by Type
4.1. Key findings
4.2. Systemic autoimmune disease diagnostics
4.2.1. Global market estimates and forecasts, 2017 – 2026
4.2.1.1. Rheumatoid arthritis
4.2.1.2. Ankylosing spondylitis
4.2.1.3. Systemic lupus erythematosus (SLE)
4.2.1.4. Others
4.2.2. Localized autoimmune disease diagnostics
4.2.2.1. Global market estimates and forecasts, 2017 – 2026
4.2.2.1.1. Multiple sclerosis
4.2.2.1.2. Type 1 diabetes
4.2.2.1.3. Hashimoto's Thyroiditis
4.2.2.1.4. Idiopathic thrombocytopenic purpura
4.2.2.1.5. Others
5. Autoimmune Disease Diagnostics Market Size and Forecast by End User
5.1. Key findings
5.2. Hospitals
5.2.1. Global market estimates and forecasts, 2017 – 2026
5.3. Diagnostics Centers
5.3.1. Global market estimates and forecasts, 2017 – 2026
5.4. Research Laboratories
5.4.1. Global market estimates and forecasts, 2017 – 2026
6. Autoimmune Disease Diagnostics Market Size and Forecast by Regions
6.1. Key findings
6.2. North America
6.2.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.2.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.2.3. U.S.
6.2.3.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.2.3.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.2.4. Canada
6.2.4.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.2.4.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.3. Europe
6.3.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.3.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.3.3. Germany
6.3.3.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.3.3.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.3.4. UK
6.3.4.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.3.4.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.3.5. France
6.3.5.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.3.5.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.3.6. Italy
6.3.6.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.3.6.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.4. Asia Pacific
6.4.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.4.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.4.3. China
6.4.3.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.4.3.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.4.4. India
6.4.4.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.4.4.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.4.5. Japan
6.4.5.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.4.5.2. Autoimmune Disease Diagnostics Market by Application, 2017 - 2026
6.4.5.3. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.4.6. Australia
6.4.6.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.4.6.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.5. Latin America
6.5.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.5.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.5.3. Brazil
6.5.3.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.5.3.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.5.4. Mexico
6.5.4.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.5.4.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
6.6. Middle East & Africa
6.6.1. Autoimmune Disease Diagnostics Market by Type, 2017 - 2026
6.6.2. Autoimmune Disease Diagnostics Market by End User, 2017 - 2026
7. Company Profiles
7.1. Hoffmann-La Roche Ltd
7.1.1. Overview
7.1.2. Financials
7.1.3. Product Benchmarking
7.1.4. Recent Developments
7.2. Siemens Healthineers
7.2.1. Overview
7.2.2. Financials
7.2.3. Product Benchmarking
7.2.4. Recent Developments
7.3. Abbott Laboratories
7.3.1. Overview
7.3.2. Financials
7.3.3. Product Benchmarking
7.3.4. Recent Developments
7.4. Beckman Coulter, Inc.
7.4.1. Overview
7.4.2. Financials
7.4.3. Product Benchmarking
7.4.4. Recent Developments
7.5. SQI Diagnostics
7.5.1. Overview
7.5.2. Financials
7.5.3. Product Benchmarking
7.5.4. Recent Developments
7.6. Quest Diagnostics
7.6.1. Overview
7.6.2. Financials
7.6.3. Product Benchmarking
7.6.4. Recent Developments
7.7. EUROIMMUN AG
7.7.1. Overview
7.7.2. Financials
7.7.3. Product Benchmarking
7.7.4. Recent Developments
7.8. Diagnostics GmbH & Co. KG
7.8.1. Overview
7.8.2. Financials
7.8.3. Product Benchmarking
7.8.4. Recent Developments
7.9. INOVA Diagnostics, Inc.
7.9.1. Overview
7.9.2. Financials
7.9.3. Product Benchmarking
7.9.4. Recent Developments
7.10. Crescendo Bioscience, Inc.
7.10.1. Overview
7.10.2. Financials
7.10.3. Product Benchmarking
7.10.4. Recent Developments
7.11. bioMerieux SA
7.11.1. Overview
7.11.2. Financials
7.11.3. Product Benchmarking
7.11.4. Recent Developments
7.12. Bio-Rad Laboratories, Inc.
7.12.1. Overview
7.12.2. Financials
7.12.3. Product Benchmarking
7.12.4. Recent Developments
7.13. Hemagen Diagnostics, Inc.
7.13.1. Overview
7.13.2. Financials
7.13.3. Product Benchmarking
7.13.4. Recent Developments